NASDAQ: GENB · Health Care / Biotechnology: Pharmaceutical Preparations

Generate Biomedicines Inc.

How Generate Biomedicines Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.0B

Price

$15.77

P/E

-9.1

EPS (TTM)

$-1.74

Dividend yield

0.0%

52-week range

$12.09–$15.77

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources